Marshfield, WI, United States of America

Duane A Tewksbury

This inventor holds 1 USPTO granted patent. Top assignee: Marshfield Clinic. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Duane A Tewksbury. Retrieved from https://idiyas.com/inventor/duane-a-tewksbury

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Duane A Tewksbury: Innovator in Angiotensinogen Receptor Modulation

Introduction

Duane A Tewksbury is a notable inventor based in Marshfield, WI (US). He has made significant contributions to the field of medical research, particularly in the area of angiotensinogen receptor modulation. His innovative approach has the potential to impact therapeutic strategies for various health conditions.

Latest Patents

Tewksbury holds a patent for a method of detecting and evaluating angiotensinogen receptor-modulating compounds using placental cells. This patent outlines a method for screening substances for their ability to modulate angiotensinogen receptor activity. The process involves contacting placental-derived cells with labeled angiotensinogen and a candidate substance, followed by determining whether the candidate substance inhibits the binding of angiotensinogen to the cells compared to a control.

Career Highlights

Duane A Tewksbury is associated with the Marshfield Clinic, where he applies his expertise in medical research. His work focuses on advancing the understanding of receptor modulation, which is crucial for developing new therapeutic interventions.

Collaborations

[Section skipped due to space constraints.]

Conclusion

Duane A Tewksbury's contributions to the field of receptor modulation exemplify the impact of innovative research on medical science. His patent reflects a significant advancement in the screening of compounds that could lead to new treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…